Genome-wide binding of GFI1 in NB4 cells
ChIP-seq analyses were conducted in NB4 cells with two antibodies against GFI1. Overall design: Identification of GFI1 binding peaks in acute promyelocytic leukemia derived NB4 cells. Two antibodies against different moiety of GFI1 were used in ChIP experiments.